Azelastine (Ascend Laboratories, LLC)
Welcome to the PulseAid listing for the Azelastine drug offered from Ascend Laboratories, LLC. This Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Ascend Laboratories, LLC |
NON-PROPRIETARY NAME: | Azelastine |
SUBSTANCE NAME: | AZELASTINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |
ROUTE: | NASAL |
DOSAGE FORM: | SPRAY, METERED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-08-18 |
END MARKETING DATE: | 0000-00-00 |
Azelastine HUMAN PRESCRIPTION DRUG Details:
Item Description | Azelastine from Ascend Laboratories, LLC |
LABELER NAME: | Ascend Laboratories, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 137(ug/1) |
START MARKETING DATE: | 2017-08-18 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 67877-477_b3299494-dd1f-4a30-a8d9-f0ca9020411b |
PRODUCT NDC: | 67877-477 |
APPLICATION NUMBER: | ANDA208156 |
Other AZELASTINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: